Non-SMC condensin I complex subunit G pseudogene 2 (NCAPGP2)

**Non-SMC condensin I complex subunit G pseudogene 2** (NCAPGP2) is classified as a *pseudogene*, meaning it is a genomic DNA sequence similar to a functional gene but generally non-functional due to accumulated mutations or loss of regulatory elements[1][5]. Pseudogenes usually do not encode functional proteins and lack the biological activity characteristic of established therapeutic targets such as receptors, enzymes, or transporters; they may sometimes regulate parental gene expression through RNA-based mechanisms such as antisense interference or as competing endogenous RNAs, but there is no evidence supporting NCAPGP2 as a therapeutic target[1][5]. No drugs, clinical biomarkers, or established disease associations or mechanisms are currently linked to this pseudogene. If the query intends NCAPGP2 to be a classic drug target or functional molecule, this is incorrect, as it does not function as a receptor, enzyme, transporter, or any traditional therapeutic target class[1][5].

Other names

NCAPGP2